Stocks Register
Akebia Therapeutics Inc. (NASDAQ: AKBA) 5.38% Incline Turns Investors Away – Stocks Register
7 days ago
Knox Daily
Akebia Therapeutics Inc. [AKBA] CEO and President makes an insider sale of 46,570 shares worth 73,581. – Knox Daily
2 days ago
Insider Monkey via Yahoo Finance
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Simply Wall St. via Yahoo Finance
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
1 day ago
Zacks via Yahoo Finance
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
3 days ago
The Woonsocket Call
Akebia Therapeutics: Q1 Earnings Snapshot
4 days ago
akebia.com
More on Yahoo Finance